Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Biochemical Pharmacology|May 15, 2002
Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug releaseSteven A Everett, Elizabeth Swann, Matthew A Naylor, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2010
Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.ACS Applied Materials & Interfaces|February 20, 2020
Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin NanocageKaouthar Bouzinab, Helen S Summers, Malcolm F G Stevens, et al.Medchemcomm|August 16, 2018
Synthesis and growth-inhibitory activities of imidazo[5,1-<i>d</i>]-1,2,3,5-tetrazine-8-carboxamides related to the anti-tumour drug temozolomide, with appended silicon, benzyl and heteromethyl groups at the 3-positionDavid Cousin, Marc G Hummersone, Tracey D Bradshaw, et al.Current Issues in Molecular Biology|January 20, 2023
<i>In Vitro</i> Anticancer Properties of Novel Bis-TriazolesMaysaa M Saleh, Duaa A Abuarqoub, Alaa M Hammad, et al.Chembiochem : a European Journal of Chemical Biology|April 21, 2011
Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibitionMarine Dufour, Chao Yan, David Siegel, et al.Chemistry & Biodiversity|May 17, 2022
Phenoxy- and Phenylamino-Heterocyclic Quinones: Synthesis and Preliminary Anti-Pancreatic Cancer ActivityPatricio Sánchez, Cristian O Salas, Sebastián Gallardo-Fuentes, et al.ACS Chemical Biology|September 22, 2011
Targeting the Hsp90 molecular chaperone with novel macrolactams. Synthesis, structural, binding, and cellular studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.Nature Chemistry|March 21, 2013
Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90Russell R A Kitson, Chuan-Hsin Chang, Rui Xiong, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
In search of effective therapies to overcome resistance to Temozolomide in brain tumoursKaouthar Bouzinab, Helen Summers, Jihong Zhang, et al.Pageof 14